GILD
GILEAD SCIENCES
Health Care·Biotechnology·UNITED STATES
$151.00
MCap $187.2B
as of 2026-09-04
Total
C2w
Fund
D1w
Quant
B1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
-0.34
Sentiment 76.9%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$151.00
Adaptive Mean
$152.03
-1.04 vs mean
Adaptive σ
1.51
MIDOS BB
$149.01 – $155.05
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+0.23
ROE
-20.7%
Z +0.98
Rev Gr
10.2%
Z -0.26
EPS Gr
—
Z +4.42
OPM Gr
-5.9%
Z -0.28
FCF Yld
5.2%
Z +0.43
EPS Surp
0.1%
Z -0.03
EPS 3mo Δ
-13.2%
Z -3.65
Fwd P/E
15.27
Z —
PEGY
0.07
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
11.84
Q6M
0.11
Q12M
5.83
MA 30/100
1.050
Bullish (MA30 > MA100)
α (Jensen)
0.5956
β (12M)
0.37
σ (12M)
0.268
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
82%
Q Percentile
83%
Divergence
-1.8
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
-10.5
RS Pctl
45%
RS Decile
D5
Persistence
2w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.